Search alternatives:
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
7601
Image 2_Temporal trends of cervical cancer demographics: a CDC WONDER database study.png
Published 2025“…Between 2015 and 2023, there was a concerning positive change in AAMR [APC of 0.1272 (95% CI –0.3393 to 1.7502)], though not statistically significant. …”
-
7602
Image 3_Temporal trends of cervical cancer demographics: a CDC WONDER database study.png
Published 2025“…Between 2015 and 2023, there was a concerning positive change in AAMR [APC of 0.1272 (95% CI –0.3393 to 1.7502)], though not statistically significant. …”
-
7603
Image 5_Temporal trends of cervical cancer demographics: a CDC WONDER database study.png
Published 2025“…Between 2015 and 2023, there was a concerning positive change in AAMR [APC of 0.1272 (95% CI –0.3393 to 1.7502)], though not statistically significant. …”
-
7604
Image 1_Temporal trends of cervical cancer demographics: a CDC WONDER database study.png
Published 2025“…Between 2015 and 2023, there was a concerning positive change in AAMR [APC of 0.1272 (95% CI –0.3393 to 1.7502)], though not statistically significant. …”
-
7605
Image 1_Emapalumab for severe cytokine release syndrome in solid tumor CAR-T: a case report.tif
Published 2025“…The hemodynamic improvement was associated with a decrease in IFN-γ and CXCL10 levels but no other cytokines. …”
-
7606
-
7607
Participants’ characteristics.
Published 2025“…First, cancer survivors reported an <i>emotional fallout episode</i> to often follow treatment, which was characterized by a loss of direction and control due to discontinuation of medical care, decreased support from healthcare professionals and their social network, and an emotional set back. …”
-
7608
Overview of the main themes and subthemes.
Published 2025“…First, cancer survivors reported an <i>emotional fallout episode</i> to often follow treatment, which was characterized by a loss of direction and control due to discontinuation of medical care, decreased support from healthcare professionals and their social network, and an emotional set back. …”
-
7609
Data from: A dominance hypothesis argument for historical genetic gains and the fixation of heterosis in octoploid strawberry
Published 2025“…Conversely, heterosis was prevalent and significant among wide hybrids, especially for fruit count, a significant driver of genetic gains for fruit yield. …”
-
7610
-
7611
-
7612
S9 Data -
Published 2025“…A comprehensive evaluation and correlation analysis of each cold tolerance index and the expression of the <i>VcCBF3</i> gene revealed that a treatment concentration of 0.4 mg·L<sup>-1</sup> had the most significant mitigating effect among the sprayed EBR concentrations of 0, 0.2, 0.4, 0.6, and 0.8 mg·L<sup>-1</sup>.…”
-
7613
S1 Data -
Published 2025“…A comprehensive evaluation and correlation analysis of each cold tolerance index and the expression of the <i>VcCBF3</i> gene revealed that a treatment concentration of 0.4 mg·L<sup>-1</sup> had the most significant mitigating effect among the sprayed EBR concentrations of 0, 0.2, 0.4, 0.6, and 0.8 mg·L<sup>-1</sup>.…”
-
7614
S4 Data -
Published 2025“…A comprehensive evaluation and correlation analysis of each cold tolerance index and the expression of the <i>VcCBF3</i> gene revealed that a treatment concentration of 0.4 mg·L<sup>-1</sup> had the most significant mitigating effect among the sprayed EBR concentrations of 0, 0.2, 0.4, 0.6, and 0.8 mg·L<sup>-1</sup>.…”
-
7615
S6 Data -
Published 2025“…A comprehensive evaluation and correlation analysis of each cold tolerance index and the expression of the <i>VcCBF3</i> gene revealed that a treatment concentration of 0.4 mg·L<sup>-1</sup> had the most significant mitigating effect among the sprayed EBR concentrations of 0, 0.2, 0.4, 0.6, and 0.8 mg·L<sup>-1</sup>.…”
-
7616
S3 Data -
Published 2025“…A comprehensive evaluation and correlation analysis of each cold tolerance index and the expression of the <i>VcCBF3</i> gene revealed that a treatment concentration of 0.4 mg·L<sup>-1</sup> had the most significant mitigating effect among the sprayed EBR concentrations of 0, 0.2, 0.4, 0.6, and 0.8 mg·L<sup>-1</sup>.…”
-
7617
S11 Data -
Published 2025“…A comprehensive evaluation and correlation analysis of each cold tolerance index and the expression of the <i>VcCBF3</i> gene revealed that a treatment concentration of 0.4 mg·L<sup>-1</sup> had the most significant mitigating effect among the sprayed EBR concentrations of 0, 0.2, 0.4, 0.6, and 0.8 mg·L<sup>-1</sup>.…”
-
7618
S8 Data -
Published 2025“…A comprehensive evaluation and correlation analysis of each cold tolerance index and the expression of the <i>VcCBF3</i> gene revealed that a treatment concentration of 0.4 mg·L<sup>-1</sup> had the most significant mitigating effect among the sprayed EBR concentrations of 0, 0.2, 0.4, 0.6, and 0.8 mg·L<sup>-1</sup>.…”
-
7619
Amount of each solution for colour reaction.
Published 2025“…A comprehensive evaluation and correlation analysis of each cold tolerance index and the expression of the <i>VcCBF3</i> gene revealed that a treatment concentration of 0.4 mg·L<sup>-1</sup> had the most significant mitigating effect among the sprayed EBR concentrations of 0, 0.2, 0.4, 0.6, and 0.8 mg·L<sup>-1</sup>.…”
-
7620
S10 Data -
Published 2025“…A comprehensive evaluation and correlation analysis of each cold tolerance index and the expression of the <i>VcCBF3</i> gene revealed that a treatment concentration of 0.4 mg·L<sup>-1</sup> had the most significant mitigating effect among the sprayed EBR concentrations of 0, 0.2, 0.4, 0.6, and 0.8 mg·L<sup>-1</sup>.…”